Search Results - "Dunkel, IJ"

Transdermal fentanyl in children with cancer pain: Feasibility, tolerability, and pharmacokinetic correlates by Collins, John J., Dunkel, Ira J., Gupta, Suneel K., Inturrisi, Charles E., Lapin, Jeanne, Palmer, Leah N., Weinstein, Sharon M., Portenoy, Russell K.

“…Objectives: (1) To assess the feasibility and tolerability of the therapeutic transdermal fentanyl system (TTS-fentanyl) by using a clinical protocol developed…”
Get full text

Selumetinib in Children with BRAF-Aberrant or Neurofibromatosis type 1-Associated Recurrent, Refractory or Progressive Low-Grade Glioma: a Multi-Center Phase II Trial by Fangusaro, J, Onar-Thomas, A, Poussaint, TY, Wu, S, Ligon, AH, Lindeman, N, Banerjee, A, Packer, RJ, Kilburn, L, Goldman, S, Pollack, IF, Qaddoumi, I, Jakacki, RI, Fisher, PG, Dhall, G, Baxter, P, Kreissman, S, Stewart, CF, Jones, DTW, Pfister, SM, Vezina, G, Stern, JS, Panigrahy, A, Patay, Z, Tamrazi, B, Jones, JY, Haque, S, Enterline, DS, Cha, S, Fisher, MJ, Doyle, LA, Smith, M, Dunkel, IJ, Fouladi, M

Get full text

Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? by Chantada, G L, Dunkel, I J, de Dávila, M T G, Abramson, D H

“…Aims: To describe the outcome of patients with non-metastatic unilateral retinoblastoma with high risk histopathological features after primary enucleation,…”
Get full text

The measurement of symptoms in children with cancer by COLLINS, J. J, BYRNES, M. E, DUNKEL, I. J, LAPIN, J, NADEL, T, THALER, H. T, POLYAK, T, RAPKIN, B, PORTENOY, R. K

“…The purpose of this study was to determine symptom prevalence, characteristics, and distress in children with cancer. The Memorial Symptom Assessment Scale…”
Get full text

Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors by MODAK, Shakeel, GARDNER, Sharon, DUNKEL, Ira J, BALMACEDA, Casilda, ROSENBLUM, Marc K, MILLER, Douglas C, HALPERN, Steven, FINLAY, Jonathan L

“…To evaluate the efficacy and toxicity of high-dose chemotherapy (HDC) followed by autologous stem-cell rescue (ASCR) in patients with relapsed or progressive…”
Get full text

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors by PAPADAKIS, V, DUNKEL, I. J, STRANDJORD, S, COCCIA, P, KAPLAN, A. M, KLEMPERER, M, FINLAY, J. L, CRAMER, L. D, KRAMER, E, PAPADOPOULOS, E, GOLDMAN, S, PACKER, R. J, WILLOUGHBY, M, BAKER, D, GARVIN, J

“…Forty-two patients (29 newly diagnosed) with high grade gliomas (n = 37), medulloblastoma (n = 2) or non-biopsied tumors (n = 3) with supratentorial (n = 24),…”
Get full text

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma by Abramson, D H, Frank, C M, Dunkel, I J

“…To evaluate the efficacy and toxicity of subconjunctival carboplatin for intraocular retinoblastoma. A phase I/II clinical trial (noncomparative case series)…”
Get more information

Patterns of Failure Using a Conformal Radiation Therapy Tumor Bed Boost for Medulloblastoma by WOLDEN, Suzanne L, DUNKEL, Ira J, SOUWEIDANE, Mark M, HAPPERSETT, Laura, KHAKOO, Yasmin, SCHUPAK, Karen, LYDEN, David, LEIBEL, Steven A

“…To assess the patterns of failure for patients with medulloblastoma receiving a conformal tumor bed boost rather than a boost to the entire posterior fossa…”
Get full text

Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: Failure of a primary chemotherapy approach by Kellie, Stewart J., Boyce, Hayden, Dunkel, Ira J., Diez, Blanca, Rosenblum, Marc, Brualdi, Lynette, Finlay, Jonathan L.

“…Purpose High rates of overall and event‐free survival have been reported in patients with intracranial germinomas treated with craniospinal radiotherapy. More…”
Get full text

Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma by Abramson, D H, Melson, M R, Dunkel, I J, Frank, C M

“…This study aimed to investigate the incidence, timing, pattern, and distribution of, as well as survival as a result of, third, fourth, and fifth primary…”
Get more information

Delayed Diagnosis of Retinoblastoma: Analysis of Degree, Cause, and Potential Consequences by Butros, Linda J, Abramson, David H, Dunkel, Ira J

“…To assess the degree, cause, and consequence of delays from presenting signs to diagnosis of retinoblastoma. A retrospective chart review was conducted of 64…”
Get full text

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors by Mason, W P, Grovas, A, Halpern, S, Dunkel, I J, Garvin, J, Heller, G, Rosenblum, M, Gardner, S, Lyden, D, Sands, S, Puccetti, D, Lindsley, K, Merchant, T E, O'Malley, B, Bayer, L, Petriccione, M M, Allen, J, Finlay, J L

“…To evaluate a strategy that avoids radiotherapy in children less than 6 years of age with newly diagnosed malignant brain tumors, by administering…”
Get more information

Longitudinal MR Spectroscopic Imaging of Pediatric Diffuse Pontine Tumors to Assess Tumor Aggression and Progression by Thakur, S.B, Karimi, S, Dunkel, I.J, Koutcher, J.A, Huang, W

“…Two pediatric patients with diffuse pontine tumors underwent MR spectroscopic imaging pre- and postradiation. Choline/creatine (Cho/Cr) and…”
Get full text

Successful treatment of metastatic retinoblastoma by Dunkel, Ira J., Aledo, Alexander, Kernan, Nancy A., Kushner, Brian, Bayer, Lisa, Gollamudi, Smitha V., Finlay, Jonathan L., Abramson, David H.

“…BACKGROUND In the past, patients with metastatic retinoblastoma have had a poor prognosis when treated with conventional modalities. In the current study, the…”
Get full text

High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors by Broniscer, Alberto, Nicolaides, Theodore P., Dunkel, Ira J., Gardner, Sharon L., Johnson Jr, James, Allen, Jeffrey C., Sposto, Richard, Finlay, Jonathan L.

“…Background Recurrent non‐cerebellar primitive neuroectodermal tumors (PNETs) carry a dismal prognosis when treated with conventional chemotherapy alone. XSWe…”
Get full text

High-dose chemotherapy with autologous stem cell rescue for brain tumors by Dunkel, Ira J., Finlay, Jonathan L.

“…The use of high-dose chemotherapy with stem cell rescue for malignant brain tumors is reviewed. Promising results have been reported in patients with…”
Get full text

New retinoblastoma tumor formation in children initially treated with systemic carboplatin by Lee, Thomas C, Hayashi, Naomi I, Dunkel, Ira J, Beaverson, Katherine, Novetsky, Danielle, Abramson, David H

“…To determine the frequency and timing of new intraocular tumor formation in children with hereditary retinoblastoma initially treated with systemic…”
Get more information

Systemic carboplatin for retinoblastoma: change in tumour size over time by Abramson, D H, Lawrence, S D, Beaverson, K L, Lee, T C, Rollins, I S, Dunkel, I J

“…Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative…”
Get full text

Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors by Guruangan, S, Dunkel, I J, Goldman, S, Garvin, J H, Rosenblum, M, Boyett, J M, Gardner, S, Merchant, T E, Gollamudi, S, Finlay, J L

“…This study evaluates the outcome of myeloablative chemotherapy and autologous bone marrow rescue (ABMR) with or without radiotherapy in children younger than 6…”
Get more information

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults by KUSHNER, B. H, CHEUNG, N.-Kv, KRAMER, K, DUNKEL, I. J, CALLEJA, E, BOULAD, F

“…Topotecan appears to be relatively unaffected by the most common multidrug resistance mechanisms, may potentiate cytotoxicity of alkylators, has good…”
Get full text